M
Medlumics — Series B · €34.4M
A €34.4M ($37M) Series B to fund product and clinical development of the AblaView catheter for atrial fibrillation. It was reported as the largest medtech round in Spain's history. Edmond de Rothschild Investment Partners (now Andera Partners) led, with new investors Seroba Life Sciences and Innogest Capital and existing investors Ysios Capital and Caixa Capital Risc.
LeadEdmond de Rothschild Investment Partners
RoundSeries B
Announced20 Mar 2017
CityMadrid
SectorHealthtech & Bio · Medtech
Source
Y
Y
The company
Investors 5
EEdmond de Rothschild Investment Partners
CCaixa Capital Risc
www.criteriabioventures.com
Profile: Criteria Capital Risc
I
Innogest Capital
SSeroba Life Sciences
YYsios Capital
ysioscapital.com